Joincare Pharmaceutical Group Industry Co (SHSE:600380) ROE % Adjusted to Book Value : 8.79% (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Joincare Pharmaceutical Group Industry Co ROE % Adjusted to Book Value?

Joincare Pharmaceutical Group Industry Co's ROE % for the quarter that ended in Mar. 2024 was 12.57%. Joincare Pharmaceutical Group Industry Co's PB Ratio for the quarter that ended in Mar. 2024 was 1.43. Joincare Pharmaceutical Group Industry Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was 8.79%.

Joincare Pharmaceutical Group Industry Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Joincare Pharmaceutical Group Industry Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Joincare Pharmaceutical Group Industry Co ROE % Adjusted to Book Value Chart

Joincare Pharmaceutical Group Industry Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

4.61

4.27

5.60

7.26

6.36

Joincare Pharmaceutical Group Industry Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															7.36	5.74	4.54	6.27	8.79

Competitive Comparison of Joincare Pharmaceutical Group Industry Co's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Joincare Pharmaceutical Group Industry Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Joincare Pharmaceutical Group Industry Co's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Joincare Pharmaceutical Group Industry Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Joincare Pharmaceutical Group Industry Co's ROE % Adjusted to Book Value falls into.

Joincare Pharmaceutical Group Industry Co ROE % Adjusted to Book Value Calculation

Joincare Pharmaceutical Group Industry Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	10.74%	/	1.69
	=	6.36%

Joincare Pharmaceutical Group Industry Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	12.57%	/	1.43
	=	8.79%

Joincare Pharmaceutical Group Industry Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Joincare Pharmaceutical Group Industry Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Joincare Pharmaceutical Group Industry Co (SHSE:600380) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Joincare Pharmaceutical Group Industry Co Ltd (SHSE:600380) » Definitions » ROE % Adjusted to Book Value

Traded in Other Exchanges

N/A

Address

No. 17 Langshan Road, Joincare Pharmaceutical Group Building, Nanshan New and High-Tech Industrial Development (, Shenzhen, Guangdong, CHN, 518057

Website

http://www.joincare.com

Joincare Pharmaceutical Group Industry Co Ltd is an integrated pharmaceutical company, the business scope covers healthcare products, APIs, final dosage forms, prescription drugs, OTCs, Chinese traditional medicine, chemical drugs, and testing agents. APIs are antibiotic series and their intermediates 7ACA, 4AA and F9. Prescription drugs focus on the realms of the digestive tract, a blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system etc. OTCs include gastrointestinal drug Dele-Livzon, Live Bifidobacterium Preparation, oral ulcer drugs Yiketie, cold medicine Antiviral Oral Granule, External use skin medicine.

Executives

Yu Xiong	Directors, senior managers
Zhao Feng Guang	senior management
Qiu Qing Feng	Directors, senior managers
Tang Ling Zhi	senior management
Lin Nan Qi	Directors, senior managers
Cao Ping Wei	Director
Feng Yan Fang	Director
Zhong Shan	senior management
Yang Dong Yun	senior management
Peng Jin Hua	Supervisors
Xie You Guo	Supervisors
Guo Xiao Yun	Supervisors
Su Qing Wen	senior management

Joincare Pharmaceutical Group Industry Co (SHSE:600380) Headlines

No Headlines